Ectonucleotide Triphosphate Diphosphohydrolase-1 (CD39) Mediates Resistance to Occlusive Arterial Thrombus Formation After Vascular Injury in Mice
Overview
Authors
Affiliations
Modulation of purinergic signaling, which is critical for vascular homeostasis and the response to vascular injury, is regulated by hydrolysis of proinflammatory ATP and/or ADP by ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD-1; CD39) to AMP, which then is hydrolyzed by ecto-5'-nucleotidase (CD73) to adenosine. We report here that compared with littermate controls (wild type), transgenic mice expressing human ENTPDase-1 were resistant to the formation of an occlusive thrombus after FeCl(3)-induced carotid artery injury. Treatment of mice with the nonhydrolyzable ADP analog, adenosine-5'-0-(2-thiodiphosphate) trilithium salt, Ado-5'-PP[S], negated the protection from thrombosis, consistent with a role for ADP in platelet recruitment and thrombus formation. ENTPD-1 expression decreased whole-blood aggregation after stimulation by ADP, an effect negated by adenosine-5'-0-(2-thiodiphosphate) trilithium salt, Ado-5'-PP[S] stimulation, and limited the ability to maintain the platelet fibrinogen receptor, glycoprotein α(IIb)/β(3), in a fully activated state, which is critical for thrombus formation. In vivo treatment with a CD73 antagonist, a nonselective adenosine-receptor antagonist, or a selective A(2A) or A(2B) adenosine-receptor antagonist, negated the resistance to thrombosis in transgenic mice expressing human ENTPD-1, suggesting a role for adenosine generation and engagement of adenosine receptors in conferring in vivo resistance to occlusive thrombosis in this model. In summary, our findings identify ENTPDase-1 modulation of purinergic signaling as a key determinant of the formation of an occlusive thrombus after vascular injury.
Impact of Estrogen on Purinergic Signaling in Microvascular Disease.
Cassavaugh J, Longhi M, Robson S Int J Mol Sci. 2025; 26(5).
PMID: 40076726 PMC: 11900469. DOI: 10.3390/ijms26052105.
Gouchoe D, Vijayakumar A, Aly A, Cui E, Essandoh M, Gumina R J Thorac Dis. 2023; 15(10):5736-5749.
PMID: 37969313 PMC: 10636473. DOI: 10.21037/jtd-23-725.
Endothelial Effects of Simultaneous Expression of Human HO-1, E5NT, and ENTPD1 in a Mouse.
Mierzejewska P, Di Marzo N, Zabielska-Kaczorowska M, Walczak I, Slominska E, Lavitrano M Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895880 PMC: 10610121. DOI: 10.3390/ph16101409.
Regulation of Hypoxic-Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury.
Cassavaugh J, Qureshi N, Csizmadia E, Longhi M, Matyal R, Robson S Pharmaceuticals (Basel). 2023; 16(3).
PMID: 36986520 PMC: 10059944. DOI: 10.3390/ph16030422.
Novitskaya T, Nishat S, Covarrubias R, Wheeler D, Chepurko E, Bermeo-Blanco O Am J Physiol Heart Circ Physiol. 2022; 323(6):H1244-H1261.
PMID: 36240436 PMC: 9722260. DOI: 10.1152/ajpheart.00138.2022.